Company: CDT
Filing Date: 2025-07-31
Form Type: S-3
Source: 0001641172-25-021729
Chunk: 36

Company: CDT Equity Inc.
Filing Date: 2025-07-31
Form: S-3
Chunk 36
---
 between the Company and Harold Eytan.                                                                                                                                                                                                                                   |
| 10.2    |     | Joint Development Agreement, dated June 3, 2025 by and between Manoira Corporation and the Company (filed as Exhibit 10.1 to the Registrant’s Current Report on Form 8-K filed on June 9, 2025 and incorporated herein by reference).                                                                                     |
| 5.1*    |     | Opinion of Thompson Hine LLP                                                                                                                                                                                                                                                                                              |
| 23.1*   |     | Consent of Thompson Hine LLP (included in Exhibit 5.1)                                                                                                                                                                                                                                                                    |
| 23.2*   |     | Consent of Marcum LLP, Independent Registered Public Accounting Firm                                                                                                                                                                                                                                                      |
| 24.1    |     | Power of Attorney (included on signature page)                                                                                                                                                                                                                                                                            |
| 107*    |     | Filing Fee Table                                                                                                                                                                                                                                                                                                          |

*Filed herewith

| II-7 |

<div align='center'>SIGNATURES</div>

Pursuant to the requirements of the Securities Act of 1933, the registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-3 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the city of Naples, State of Florida, on July 31, 2025.

| CONDUIT              
 PHARMACEUTICALS INC. |                   |
| By:                  | /s/               
 Andrew Regan      |
| Name:                | Andrew            
 Regan             |
| Title:               | Chief             
 Executive Officer |

| II-8 |

<div align='center'>POWER OF ATTORNEY</div>

KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below hereby constitutes and appoints Andrew Regan and/or James Bligh, as his true and lawful agent, proxy and attorney-in-fact, with full power of substitution and resubstitution, for him and in his name, place and stead, in any and all capacities, to (i) act on, sign and file with the Securities and Exchange Commission any and all amendments (including post-effective amendments) to this registration statement together with all schedules and exhibits thereto and any subsequent registration statement filed pursuant to Rule 462(b) under the Securities Act of 1933, as amended, together with all schedules and exhibits thereto